Ballentine Partners LLC Has $1.19 Million Stake in Relx Plc $RELX

Ballentine Partners LLC grew its position in shares of Relx Plc (NYSE:RELX) by 3.9% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 21,939 shares of the technology company’s stock after buying an additional 828 shares during the quarter. Ballentine Partners LLC’s holdings in Relx were worth $1,192,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also made changes to their positions in the company. Larson Financial Group LLC raised its stake in shares of Relx by 612.5% in the 1st quarter. Larson Financial Group LLC now owns 513 shares of the technology company’s stock valued at $26,000 after acquiring an additional 441 shares in the last quarter. WPG Advisers LLC bought a new position in shares of Relx in the 1st quarter valued at approximately $28,000. Golden State Wealth Management LLC raised its stake in shares of Relx by 100.0% in the 1st quarter. Golden State Wealth Management LLC now owns 588 shares of the technology company’s stock valued at $30,000 after acquiring an additional 294 shares in the last quarter. Cornerstone Planning Group LLC raised its stake in shares of Relx by 325.2% in the 1st quarter. Cornerstone Planning Group LLC now owns 693 shares of the technology company’s stock valued at $37,000 after acquiring an additional 530 shares in the last quarter. Finally, UMB Bank n.a. raised its stake in shares of Relx by 19.1% in the 2nd quarter. UMB Bank n.a. now owns 1,634 shares of the technology company’s stock valued at $89,000 after acquiring an additional 262 shares in the last quarter. 15.02% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on RELX. Kepler Capital Markets raised Relx from a “hold” rating to a “strong-buy” rating in a research note on Thursday, September 18th. Morgan Stanley reissued an “overweight” rating on shares of Relx in a research note on Thursday, September 11th. Finally, Wall Street Zen downgraded Relx from a “buy” rating to a “hold” rating in a research note on Friday, September 5th. One investment analyst has rated the stock with a Strong Buy rating and four have assigned a Buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Buy”.

Relx Stock Performance

Shares of NYSE RELX opened at $46.30 on Friday. The company has a quick ratio of 0.42, a current ratio of 0.47 and a debt-to-equity ratio of 2.55. The business’s 50 day moving average is $48.57 and its two-hundred day moving average is $51.01. The company has a market cap of $84.84 billion, a P/E ratio of 24.89, a P/E/G ratio of 3.02 and a beta of 0.87. Relx Plc has a 12 month low of $44.19 and a 12 month high of $56.33.

Relx Cuts Dividend

The firm also recently declared a semi-annual dividend, which was paid on Tuesday, September 16th. Shareholders of record on Friday, August 8th were given a $0.2634 dividend. This represents a yield of 170.0%. The ex-dividend date of this dividend was Friday, August 8th. Relx’s payout ratio is currently 28.49%.

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.